Dr. Riemann and Dr. Amir have financial interest in Cognitive Retraining Technologies Incorporated, which has licensed elements of the technology described in this study for commercial purposes. Jennie Kuckertz, Michelle Rozenman, and Dr. Weersing report no conflicts of interest.
AUGMENTATION OF YOUTH COGNITIVE BEHAVIORAL AND PHARMACOLOGICAL INTERVENTIONS WITH ATTENTION MODIFICATION: A PRELIMINARY INVESTIGATION
Article first published online: 8 MAY 2013
© 2013 Wiley Periodicals, Inc.
Depression and Anxiety
Volume 30, Issue 9, pages 822–828, September 2013
How to Cite
Riemann, B. C., Kuckertz, J. M., Rozenman, M., Weersing, V. R. and Amir, N. (2013), AUGMENTATION OF YOUTH COGNITIVE BEHAVIORAL AND PHARMACOLOGICAL INTERVENTIONS WITH ATTENTION MODIFICATION: A PRELIMINARY INVESTIGATION. Depress. Anxiety, 30: 822–828. doi: 10.1002/da.22127
- Issue published online: 3 SEP 2013
- Article first published online: 8 MAY 2013
- Manuscript Accepted: 22 FEB 2013
- Manuscript Revised: 22 DEC 2012
- Manuscript Received: 3 DEC 2012
- anxiety disorders;
- attention training;
- cognitive bias modification;
Recent research suggests the efficacy of attention modification programs (AMP) in treating adult anxiety. Though some research supports the success of AMP treatment in anxious youths,[2, 3] to date no study has examined the efficacy of AMP as an adjunctive treatment to other psychosocial and pharmacological interventions for anxious youths within the community.
In the current study, we examined the efficacy of AMP as an adjunctive treatment to standard care at a residential anxiety treatment facility. Adolescents (N = 42) completed either an active (attention modification program, AMP; n = 21) or a control (attention control condition, ACC; n = 21) condition, in addition to the facility's standard treatment protocol, which included cognitive behavioral therapy with or without medication.
While anxiety symptoms decreased for participants across both groups, participants in the AMP group experienced a significantly greater decrease in anxiety symptoms from point of intake to point of discharge, in comparison to participants in the ACC group.
These results suggest that AMP is an effective adjunctive treatment to the standard treatments of choice for anxiety disorders, and may hold promise for improving treatment response in highly anxious youths.